Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Catalyst Pharmaceuticals (CPRX) Shares Issued (2017 - 2025)

Historic Shares Issued for Catalyst Pharmaceuticals (CPRX) over the last 15 years, with Q3 2025 value amounting to $5.8 million.

  • Catalyst Pharmaceuticals' Shares Issued changed N/A to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year decrease of 9097.13%. This contributed to the annual value of $141.0 million for FY2024, which is 495014.33% up from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its Shares Issued stood at $5.8 million for Q3 2025.
  • Catalyst Pharmaceuticals' Shares Issued's 5-year high stood at $141.0 million during Q1 2024, with a 5-year trough of $188000.0 in Q1 2021.
  • Moreover, its 5-year median value for Shares Issued was $1.3 million (2022), whereas its average is $10.6 million.
  • Its Shares Issued has fluctuated over the past 5 years, first soared by 1100236.22% in 2024, then plummeted by 9660.5% in 2025.
  • Quarter analysis of 5 years shows Catalyst Pharmaceuticals' Shares Issued stood at $685000.0 in 2021, then surged by 367.3% to $3.2 million in 2022, then plummeted by 78.35% to $693000.0 in 2023, then surged by 20246.32% to $141.0 million in 2024, then crashed by 95.89% to $5.8 million in 2025.
  • Its Shares Issued was $5.8 million in Q3 2025, compared to $2.2 million in Q2 2025 and $4.8 million in Q1 2025.